Schedule 13G ownership disclosure

ARIAD PHARMACEUTICALS INC

Security class unavailable · CUSIP: 04033A100

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,493,458
Percent of class
5.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-16-002903
Form type
SC 13G
Filer
ARIAD PHARMACEUTICALS INC
CIK
CIK 884731
Filed
Feb 10, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub